Company profile for ModeX Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ModeX is dedicated to developing next-generation multispecific biologics for cancers and infectious diseases. ModeX’s platforms unite the power of multiple biologics in a single molecule to create multispecific antibodies and vaccines with unprecedented versatility and potency against complex diseases. In May 2022, we merged with OPKO Health to begin a major new phase for both companies as a united entity with a shared visio...
ModeX is dedicated to developing next-generation multispecific biologics for cancers and infectious diseases. ModeX’s platforms unite the power of multiple biologics in a single molecule to create multispecific antibodies and vaccines with unprecedented versatility and potency against complex diseases. In May 2022, we merged with OPKO Health to begin a major new phase for both companies as a united entity with a shared vision for transforming medicine.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
22 Strathmore Road Natick, MA 01760
Telephone
Telephone
+1 8572339936
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/regeneron-pledges-more-1b-biobucks-modex-multispecific-antibodies

FIERCE BIOTECH
29 Oct 2025

https://www.globenewswire.com/news-release/2025/10/28/3175365/0/en/OPKO-Health-s-ModeX-Therapeutics-Begins-Clinical-Trial-of-MDX2004-for-the-Treatment-of-Advanced-Cancers.html

GLOBENEWSWIRE
28 Oct 2025

https://www.globenewswire.com/news-release/2025/06/09/3095774/0/en/OPKO-Health-s-ModeX-Therapeutics-Announces-Formation-of-Scientific-Advisory-Board-with-Leaders-at-the-Forefront-of-Immunology-and-Oncology-Drug-Development.html

GLOBENEWSWIRE
09 Jun 2025

https://www.globenewswire.com/news-release/2025/01/07/3005382/0/en/OPKO-Health-s-ModeX-Therapeutics-Announces-Epstein-Barr-Virus-Vaccine-Candidate-Enters-Phase-I-Clinical-Study-in-Collaboration-with-Merck.html

GLOBENEWSWIRE
07 Jan 2025

https://www.fiercebiotech.com/research/modexs-multispecific-antibodies-shut-down-covid-variants-and-advance-clinic-35m-more-barda

FIERCE BIOTECH
09 Oct 2024

https://www.globenewswire.com/news-release/2024/10/07/2958852/0/en/ModeX-Therapeutics-Secures-35-Million-BARDA-Supplement-to-Develop-COVID-Multispecific-Antibodies-and-16-Million-to-Initiate-Influenza-Program.html

GLOBENEWSWIRE
07 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty